Clinical Trial Update: Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis [Phase 2]

View source ↗

Summary

This update reports results from a Phase 2 study evaluating the activity, safety, and tolerability of SRT2104 in adults with moderate to severe plaque-type psor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• SRT2104 (SRT2104)

Snippet

Sponsor: Sirtris, a GSK Company | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2017-10-13